Maternal and foetal outcome in COVID-19 infection: what we learnt and what lies ahead

Authors

  • Ambreen Shaikh Department of Obstetrics and Gynaecology, Seth G S Medical College and KEMH, Mumbai, Maharashtra, India
  • Niranjan Mayadeo Department of Obstetrics and Gynaecology, Seth G S Medical College and KEMH, Mumbai, Maharashtra, India
  • Jyotsna Dwivedi Department of Obstetrics and Gynaecology, Seth G S Medical College and KEMH, Mumbai, Maharashtra, India
  • Madhura Mandlik Department of Obstetrics and Gynaecology, Seth G S Medical College and KEMH, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20243935

Keywords:

COVID-19, Third wave, Maternal outcome, Foetal outcome, Preterm birth

Abstract

Background: The world has seen 16 major pandemics since its inception. COVID-19 (coronavirus disease 2019), being the most recent one, was a pandemic the world faced, due to a new coronavirus called the SARS-CoV-2. It originated in Wuhan, China and soon grappled the whole world. The World Health Organization (WHO) declared COVID-19 a global pandemic on March 11, 2020. This pandemic lasted for three years, with the WHO finally declaring an end to the global health emergency on May 5, 2023 Pregnant women remain a vulnerable population for such respiratory illnesses that pose a risk to not only the mother but also the foetus.

Methods: This was a retrospective study conducted in a tertiary care, premium institute in Mumbai, during the third wave of COVID 19 in India. Primary objective was to assess maternal and foetal outcome in COVID 19 positive patients. Secondary objective was to assess rate of preterm delivery in COVID 19 positive patients.

Results: 103 COVID 19 positive women were included in the study. 74.7% patients who had tested positive, were asymptomatic. There was no statistical difference between the mode of delivery of patients. The most common comorbidity in the positive patients was pre-eclampsia (15.53%).  2.9% patients received Remdesivir and 2.9% received Favipravir. 58.2% were transferred to a dedicated COVID 19 hospital post-delivery. There were three intrauterine foetal demises. 18 (17.47%) women delivered preterm under 37 weeks. The rate of preterm delivery was significantly higher in COVID-positive patients (p-value <0.00025).

Conclusions: The COVID-19 pandemic posed significant challenges for healthcare workers and policymakers. It is crucial for clinicians to learn from this experience to enhance preparedness and mitigate future adversities.

Metrics

Metrics Loading ...

References

Maramorosch K. Advances in virus research vol. 81. Amsterdam: Elsevier; 2011.

Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, Genetic Recombination and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24(6):490–502.

Vaughan A. Omicron emerges. New Sci. 2021;252(3363):7.

Baig R, Mateen MA, Aborode AT, Novman S, Matheen IA, Siddiqui OS, Ahmed FA. Third wave in India and an update on vaccination: A short communication. Ann Med Surg. 2022;75:876.

Kumar D, Verma S, Mysorekar IU. COVID-19 and pregnancy: clinical outcomes; mechanisms and vaccine efficacy. Transl Res. 2023;251:84–95.

Zhang SX, Arroyo Marioli F, Gao R, Wang S. A second wave, what COVID do people mean by waves-a working definition of epidemic waves. Risk Manag Healthc Policy. 2021;14:3775–82.

Liu H, Zhang Q, Wei P, Chen Z, Aviszus K, Yang J, et al. The basis of a more contagious 501Y.V1 variant of SARS-COV-2. Available from: http://biorxiv.org/lookup. Accessed on 21 August 2024.

Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, et al. 501Y. V2 and 501Y. V3 variants of SARS-CoV-2 lose binding to Bamlanivimab in vitro. InMAbs. 2021;13(1):1919285.

Adhikari EH, MacDonald L, SoRelle JA, Morse J, Pruszynski J, Spong CY. COVID-19 cases and disease severity in pregnancy and neonatal positivity associated with delta (B.1.617.2) and Omicron (B.1.1.529) Variant Predominance. JAMA. 2022;19;327(15):1500.

Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292–7.

Crovetto F, Crispi F, Llurba E, Pascal R, Larroya M, Trilla C, et al. Impact of severe acute respiratory syndrome coronavirus 2 infection on pregnancy outcomes: a population-based study. Clin Infect Dis. 2021;16;73(10):1768–75.

Ahmed A, Rezai H, Broadway-Stringer S. Evidence-Based Revised View of the Pathophysiology of Preeclampsia. In: Islam MdS, editor. Hypertension: from basic research to clinical practice [Internet]. Cham: Springer International Publishing. 2017: 355–74.

Diriba K, Awulachew E, Getu E. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV and SARS-CoV) during pregnancy and the possibility of vertical maternal–fetal transmission: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):39.

Staff AC. The two-stage placental model of preeclampsia: An update. J Reprod Immunol. 2019;2:134–5.

Giardini V, Gambacorti-Passerini C, Casati M, Carrer A, Vergani P. Can Similarities between the Pathogenesis of Preeclampsia and COVID-19 Increase the Understanding of COVID-19 Int J .Transl Med. 2022;2(2):186–97.

Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the intercovid multinational cohort study. JAMA Pediatr. 2021;1;175(8):817.

Xiong S, Liu L, Lin F, Shi J, Han L, Liu H, et al. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study. BMC Infect Dis. 2020;20(1):787.

Miyamoto M, Perreand E, Mangione M, Patel M, Cojocaru L, Seung H, et al. Mode of Delivery in Patients with COVID-19. Am J Obstet Gynecol. 2022;226(1):582–3.

Magawa S, Maki S, Tamaishi Y, Enomoto N, Takakura S, Nii M, et al. Modes of delivery and indications in women with COVID-19: a regional observational study in Japan. J Obstet Gynaecol. 2024;31;44(1):2362968.

Jorgensen SCJ, Davis MR, Lapinsky SE. A review of remdesivir for COVID-19 in pregnancy and lactation. J Antimicrob Chemother. 2021;24;77(1):24–30.

Smith ER, Oakley E, Grandner GW, Ferguson K, Farooq F, Afshar Y, et al. Adverse maternal, fetal and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis. BMJ Glob Health. 2023;8(1):9495.

Gurol-Urganci I, Jardine JE, Carroll F, Draycott T, Dunn G, Fremeaux A, et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol. 2021;225(5):52.

Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S, et al. A systematic scoping review of COVID‐19 during pregnancy and childbirth. Int J Gynecol Obstet. 2020;150(1):47–52.

Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2):100107.

Downloads

Published

2024-12-27

How to Cite

Shaikh, A., Mayadeo, N., Dwivedi, J., & Mandlik, M. (2024). Maternal and foetal outcome in COVID-19 infection: what we learnt and what lies ahead. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 14(1), 117–122. https://doi.org/10.18203/2320-1770.ijrcog20243935

Issue

Section

Original Research Articles